This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Monsanto Technology LLC. Active years: 2009-2014.
Company Filing History:
Years Active: 2009-2014
Title: Michelle Lacy: Innovator in Plant Biotechnology
Introduction
Michelle Lacy is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of plant biotechnology, holding a total of 5 patents. Her work focuses on the development of non-coding regulatory elements that enhance the expression of transgenes in plants.
Latest Patents
Among her latest patents, one invention provides non-coding regulatory element polynucleotide molecules isolated from the lipid transfer protein (LTP) gene. This invention is useful for expressing transgenes in plants. It further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants, and seeds containing the regulatory polynucleotide sequences, along with methods for preparing and using the same. Another notable patent involves non-coding regulatory element polynucleotide molecules isolated from the transcription factor Nuclear Factor B (NFB2) gene, which also aids in expressing transgenes in plants.
Career Highlights
Michelle Lacy is currently employed at Monsanto Technology LLC, where she continues to innovate in the field of plant biotechnology. Her research has led to advancements that are crucial for agricultural development and sustainability.
Collaborations
Some of her notable coworkers include Wei Wu and Qi Wang, who collaborate with her on various projects within the company.
Conclusion
Michelle Lacy's contributions to plant biotechnology through her patents and research at Monsanto Technology LLC highlight her role as a leading inventor in the field. Her work is paving the way for future innovations in agricultural technology.